{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:09:51Z","timestamp":1770815391967,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00417-015-3202-0","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T22:43:44Z","timestamp":1446072224000},"page":"391-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combined intravitreal melphalan and intravenous\/intra-arterial chemotherapy for retinoblastoma with vitreous seeds"],"prefix":"10.1007","volume":"254","author":[{"given":"Ji Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Min","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuhl Joo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"3202_CR1","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","volume":"113","author":"CL Shields","year":"2006","unstructured":"Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276\u20132280","journal-title":"Ophthalmology"},{"key":"3202_CR2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ophtha.2008.10.014","volume":"116","author":"CL Shields","year":"2009","unstructured":"Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA (2009) Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology 116:544\u2013551, e541","journal-title":"Ophthalmology"},{"key":"3202_CR3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","volume":"129","author":"CL Shields","year":"2011","unstructured":"Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA (2011) Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129:1399\u20131406","journal-title":"Arch Ophthalmol"},{"key":"3202_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","volume":"96","author":"DH Abramson","year":"2012","unstructured":"Abramson DH, Marr BP, Dunkel IJ, Brodie S, Zabor EC, Driscoll SJ, Gobin YP (2012) Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results. Br J Ophthalmol 96:499\u2013502","journal-title":"Br J Ophthalmol"},{"key":"3202_CR5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","volume":"96","author":"FL Munier","year":"2012","unstructured":"Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M (2012) Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol 96:1078\u20131083","journal-title":"Br J Ophthalmol"},{"key":"3202_CR6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","volume":"130","author":"F Ghassemi","year":"2012","unstructured":"Ghassemi F, Shields CL (2012) Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol 130:1268\u20131271","journal-title":"Arch Ophthalmol"},{"key":"3202_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","volume":"132","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA (2014) Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol 132:319\u2013325","journal-title":"JAMA Ophthalmol"},{"key":"3202_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","volume":"96","author":"FL Munier","year":"2012","unstructured":"Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M (2012) Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. Br J Ophthalmol 96:1084\u20131087","journal-title":"Br J Ophthalmol"},{"key":"3202_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjophthalmol-2013-303885","volume":"98","author":"SJ Smith","year":"2014","unstructured":"Smith SJ, Smith BD, Mohney BG (2014) Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol 98:292\u2013297","journal-title":"Br J Ophthalmol"},{"key":"3202_CR10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","volume":"132","author":"F Ghassemi","year":"2014","unstructured":"Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R (2014) Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmol 132:936\u2013941","journal-title":"JAMA Ophthalmol"},{"key":"3202_CR11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archophthalmol.2011.151","volume":"129","author":"CL Shields","year":"2011","unstructured":"Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, Shields JA (2011) Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol 129:1407\u20131415","journal-title":"Arch Ophthalmol"},{"key":"3202_CR12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2011.08.045","volume":"119","author":"WJ Muen","year":"2012","unstructured":"Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA (2012) Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology 119:611\u2013616","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3202-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3202-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3202-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:56Z","timestamp":1559058056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3202-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3202"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3202-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}